WATERTOWN, Mass. - EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT), currently valued at $535 million, announced positive results from the Phase 2 VERONA clinical trial of DURAVYU™, its ...
Good' (HDL) cholesterol, usually considered to be beneficial for health, may be linked to a heightened risk of the serious ...
"Good" (HDL) cholesterol, usually considered to be beneficial for health, may be linked to a heightened risk of the serious ...
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...
A Black Country sight loss charity is calling on businesses to come forward and sponsor a charity ball to celebrate its 150th ...
AI Optics' Sentinel Camera, a handheld retinal imaging system, has received FDA 510 (k) clearance, enhancing accessibility to ...
GP Dr Roger Henderson provides an overview of the chronic complications of diabetes and the key preventive measures ...
Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback